1. ¹Department of Oral Pathology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan
2. ²Department of Pathology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
3. ³Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
4. ⁴Division of Pathology, Sumitomo Hospital, Osaka, Osaka, Japan
5. ⁵Department of Molecular Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

Correspondence: Dr S Toyosawa, DDS, PhD, Department of Oral Pathology, Osaka University Graduate School of Dentistry, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail: toyosawa@dent.osaka-u.ac.jp

Received 21 March 2003; Revised 1 October 2003; Accepted 6 October 2003; Published online 20 February 2004.

Abstract

Oncogenic osteomalacia, which is characterized by renal phosphate wasting, low serum 1, 25-dihydroxyvitamin D, and osteomalacia, is caused by mesenchymal neoplasms that are termed phosphaturic mesenchymal tumors (PMTs). As PMTs are usually small and lack specific histological features, the pathological identification of PMTs is difficult. Dentin matrix protein 1 (DMP1) is an acidic phosphoprotein expressed in mineralized tissues including bone, tooth, and hypertrophic cartilage. Increased expression of DMP1 gene in PMTs has been reported by using differential cDNA screening. In the present study, DMP1 expression in PMTs and other soft tissue tumors was analyzed immunohistochemically to verify its utility in the differential diagnosis of PMTs. Anti-DMP1 polyclonal antibody was raised against the C-terminal sequence of DMP1. Three cases with PMTs and 11 other soft tissue tumors (two malignant hemangiopericytomas, three solitary fibrous tumors, three synovial sarcomas, and three malignant peripheral nerve sheath tumors) were analyzed for DMP1 expression. DMP1 expression was observed in all of the three cases with PMTs, but never found in other soft tissue tumors examined. DMP1 was detected in the extracellular matrix with myxomatous features or around capillary vessels, and in dystrophic calcified sites. Paranuclear DMP1 staining in the tumor cells was also observed. These findings indicate that DMP1 immunohistochemistry is a useful tool for identifying PMTs.